ViuHealth has raised $200K in total across 1 funding round.
ViuHealth's investors include Techstars Impact Fund.
ViuHealth is a technology company that builds a holistic virtual care platform specifically designed for individuals with autoimmune diseases. It offers a remote care application that connects patients with a dedicated clinical care team—including nurse practitioners, registered nurses, and certified health coaches—to provide personalized health coaching, symptom tracking, and management tools. The platform serves both patients and physicians by improving daily disease management, reducing flares, and supporting care between doctor visits. ViuHealth’s solution also enables physicians to expand virtual care offerings and uncover new reimbursement opportunities, contributing to better patient outcomes and practice revenue growth[1][3][4].
Founded in 2018 (initially as DrugViu), ViuHealth evolved from a real-world evidence (RWE) and clinical research platform focused on improving diverse patient representation in autoimmune clinical trials to a broader care management platform. The company rebranded to ViuHealth in 2022 to reflect its shift toward providing comprehensive digital care solutions beyond pharmaceutical treatments. Its CEO, Kwaku Owusu, leads the company from its New York City headquarters. Early pivotal moments include partnerships with organizations like The Leaders Rheum and Coral Genomics to enhance rheumatology care and minority patient outcomes in inflammatory bowel disease[1][2].
ViuHealth rides the growing trend of digital health and virtual care, particularly in chronic disease management. The timing is critical as autoimmune diseases require continuous, personalized care that traditional episodic physician visits cannot fully address. Market forces such as increased telehealth adoption, demand for patient-centered care, and healthcare reimbursement reforms favor platforms like ViuHealth. By partnering with specialists and leveraging technology, ViuHealth influences the ecosystem by improving patient outcomes, supporting independent practices, and advancing inclusive clinical research[1][2][3].
ViuHealth is poised to expand its impact by deepening partnerships with rheumatology providers and broadening its patient base. Trends shaping its journey include the rise of personalized medicine, integration of real-world data in clinical decision-making, and increasing demand for virtual chronic care solutions. Its influence may evolve toward becoming a standard adjunct to autoimmune care, driving better health outcomes and reshaping how chronic autoimmune diseases are managed digitally.
In summary, ViuHealth’s transformation from a clinical trial recruitment platform to a comprehensive autoimmune care management solution highlights its commitment to improving patient lives through technology and personalized care.
ViuHealth has raised $200K across 1 funding round. Most recently, it raised $200K Seed in May 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2019 | $200K Seed | Techstars Impact Fund |